Key result
The LPL 447Ter variant was associated with a lower risk of metabolic syndrome compared to the reference variant, while the 291Ser variant showed no difference.
Why the study?
Are common LPL variants (447Ter and 291Ser) associated with the presence of metabolic syndrome in adults without known cardiovascular disease?
Cross-Sectional (n=2,348)
Are common LPL variants (447Ter and 291Ser) associated with the presence of metabolic syndrome in adults without known cardiovascular disease?
The 447Ter LPL variant is associated with a lower risk of metabolic syndrome, primarily driven by its favorable effect on triglycerides and HDL cholesterol.
Answers are grounded in this paper and cite their sources.
Supports 447Ter variant as protective for metabolic syndrome; hypothesis-generating and requires prospective validation before any clinical use.
BACKGROUND: Common lipoprotein lipase (LPL) variants are important determinants of triglycerides (TG) and high-density lipoprotein (HDL) cholesterol (C) concentrations. High TG/low HDL-C tend to cluster with hypertension, glucose intolerance, and abdominal obesity and comprise the metabolic syndrome (MetS). The role of LPL variants as a cause of MetS is unclear. This study investigated the relationship between two common LPL variants and the presence of MetS and its individual components. METHODS: Cross-sectional study, including 2348 Danish women (50.7%) and men, age 41-72 years, without known cardiovascular disease. Carrier status for the two common LPL variants: 447Ter (low TG/high HDL-C) and 291Ser (high TG/low HDL-C) was determined. The prevalence of MetS according to the National Cholesterol Education Program criteria was 16.6%. RESULTS: Of the 2348 participants, 19.8% had the 447Ter variant and 4.9% had the 291Ser variant. Compared with the reference variant, the prevalence of MetS was lower in carriers of the 447Ter variant (11.2% vs. 17.9%, P < 0.001) but with no difference in carriers of the 291Ser variant (18.4% vs. 16.5%, P = 0.59). Adjusted for age, sex, smoking, physical activity, alcohol consumption, and highest sex-specific insulin quartile, the relative risk of MetS was 0.63 (95% confidence interval [CI] 0.45-0.89, P < 0.01) for carriers of the 447Ter variant and 1.20 (95% CI 0.70-2.03, P > 0.05) for carriers of the 291Ser variant. Both LPL variants were associated with high TG/low HDL-C (P < 0.01), but not with the MetS components waist circumference, hypertension, and glucose intolerance (P > 0.05). CONCLUSION: The two common LPL variants were associated with MetS through their effect on high TG/low HDL-C.
No takes yet. Share an insight, caveat, or question.
Vishram et al. (2016) conducted a cross-sectional in Metabolic syndrome (n=2,348). LPL 447Ter variant vs. Reference variant was evaluated on Metabolic syndrome (RR 0.63, 95% CI 0.45-0.89, p=<0.01). The LPL 447Ter variant was associated with a lower risk of metabolic syndrome compared to the reference variant, while the 291Ser variant showed no difference.
Synapse has enriched 10 related papers. Consider them for comparative context: